Modulating the endotheliopathy of trauma: Factor concentrate versus fresh frozen plasma.

J Trauma Acute Care Surg

From the Blood Systems Research Institute (S.P., D.R.P., G.B.); and Department of Laboratory Medicine (S.P., D.R.B., G.B.), University of California San Francisco, San Francisco, California; Department of Surgery (J.B.H.), University of Texas-Houston Medical School, Houston, Texas; and Department of

Published: April 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Transfusion of balanced ratios of plasma to platelets and red blood cells has been shown to reduce early death from exsanguination in trauma patients. Aside from hemostasis, recent work has shown that plasma reduces vascular endothelial permeability, inflammation, and organ edema after hemorrhagic shock (HS), all components of the endotheliopathy of trauma. We hypothesized that Kcentra could have protective effects on the endotheliopathy of trauma comparable with fresh frozen plasma (FFP).

Methods: In vitro, endothelial cell (EC) barrier function was assessed by measuring changes in transendothelial electrical resistance for Kcentra, FFP, and albumin. In vivo, a modified Miles assay was used on mice to study the effects of Kcentra, FFP, and albumin on vascular permeability induced by VEGF-A. The same groups were studied in a second in vivo model of pulmonary vascular leak induced by HS and laparotomy. The identification of proteins in Kcentra was assessed by liquid chromatography/mass spectrometry.

Results: We found that FFP and Kcentra inhibit EC permeability. We also found that Kcentra and FFP have equivalent capacity to restore EC adherens junction breakdown induced by VEGF-A. In vivo, we found that Kcentra and FFP, but not albumin, significantly inhibited vascular permeability induced by VEGF-A and HS-induced vascular permeability in mice. Investigation of the protein content of Kcentra by mass spectroscopy revealed that there are a number of proteins in Kcentra, derived from plasma that may have contributory roles in the noted effects of Kcentra on vascular leak.

Conclusion: Taken together, we have demonstrated that FFP and Kcentra inhibit vascular permeability in vivo and in vitro. These beneficial effects of Kcentra may be due in part to the modulation of vascular function by soluble factors present in Kcentra aside from the known clotting factors II, VII, IX, and X. The clinical implications of these findings are unknown and warrant further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000000961DOI Listing

Publication Analysis

Top Keywords

kcentra ffp
16
vascular permeability
16
kcentra
13
endotheliopathy trauma
12
ffp albumin
12
effects kcentra
12
induced vegf-a
12
fresh frozen
8
frozen plasma
8
vascular
8

Similar Publications

BackgroundThe haemostatic system plays a role in development of valvular vegetations and systemic activation of coagulation, contributing to both thrombosis and consumption coagulopathy. Patients with infective endocarditis undergoing valvular surgery pose unique challenges to the surgical team. Rotational thromboelastometry (ROTEM), a point-of-care viscoelastic clotting test, can help assess coagulation and guide therapy.

View Article and Find Full Text PDF

Coagulopathy and bleeding are common complications following cardiac surgery, often requiring the use of hemostatic agents such as prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP). This systematic review and meta-analysis compared the efficacy and safety of PCC versus FFP in adult patients undergoing cardiac surgery complicated by bleeding or coagulopathy. A comprehensive search of PubMed, Embase, and Web of Science was conducted from inception to March 30, 2025, identifying randomized controlled trials comparing these interventions.

View Article and Find Full Text PDF

Comparison of Hemostatic Activity in Canine Leukoreduced Cryoprecipitate, Cryopoor Plasma, and Fresh Plasma.

Vet Clin Pathol

June 2025

Veterinary Transfusion Research Laboratory (REVLab), Department of Veterinary Medicine and Animal Science (DIVAS), University of Milan, Lodi, Italy.

Background: To date, no studies have reported the evaluation of hemostatic activity in canine leukoreduced cryoprecipitate (LR-CRYO) and leukoreduced cryopoor plasma (LR-CPP).

Objectives: We aimed to compare the hemostatic activity of LR-CRYO and LR-CPP to leukoreduced fresh plasma (LR-FP) and to evaluate the preservation of LR-CRYO by refrigeration and refreezing after thawing.

Methods: Four hundred fifty milliliters of fresh blood was collected from ten donor dogs, leukoreduced, and separated into LR-FP, then frozen (-20°C) to obtain leukoreduced fresh frozen plasma (LR-FFP).

View Article and Find Full Text PDF

Background: Despite efforts to standardise practice using evidence-based guidelines, fresh frozen plasma (FFP) remains the blood component most frequently prescribed inappropriately. This study assessed the appropriateness of FFP transfusion in two tertiary teaching hospitals and analysed the characteristics of appropriate and inappropriate transfusions.

Methods: Patients who had undergone FFP transfusion between October and December 2022 at two tertiary teaching hospitals were retrospectively analysed.

View Article and Find Full Text PDF